• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Section Contents Menu

Drug Safety and Availability

FDA Drug Safety Newsletter Index

Newsletter Index, Volume 2, 2009
ABCDEFGHIJKLM
NOPQRSTUVWXYZ


 

An index to brand-name drugs, generic drugs and health issues discussed in Drug Safety Newsletter articles. A list of drug safety alerts and communications can be found on the Index to Drug-Specific Information.

Newsletter Index, Volume 1, 2007-2008

 

Page numbers refer to the print version (PDF).
 



A

Abacavir, 5-6

Acute Renal Failure, 13-15

ADHD, 7-9

Ageusia, 26-27

AndroGel, 21-23

Anosmia, 26-27

Arginine, 16-18

Atomoxetine, 7-9

 



B

Bupropion, 1-4


 



C

Calcium, 24-25 

Cardiopulmonary Arrest, 24-25

Ceftriaxone, 24-25 

Chantix, 1-4



D
Drug-Drug Interaction, 24-25  


 



E

Epzicom, 5-6


 



H

Hepatotoxicity, 7-9

HLA-B*570, 5-6
Hypersensitivity Reaction, 5-6


 



 

L

 

Leg Cramps, 11-13
 

Loss of Sense of Smell, 26-27
  

Loss of Sense of Taste, 26-27

 

 



M

 

Medication Errors, 16-18

 

 



N

Neonates, 24-25

Nicotine, 1-4


 



O

 

Off-label Use, 11-13

 


 



 

P

 

Pediatrics, 1-4

 


 



Q

 

Qualaquin, 11-13

 

Quinine Sulfate, 11-13

 


 


 

R 

 

Reclast, 13-15

 

Renal Impairment, 13-15

 

R-Gene 10, 16-18

 


 


 

S

Secondary Exposure

Skin Patch Testing, 5-6

Strattera, 7-9
Suicide, 1-4


 



T

Testim, 21-23

Topical Testosterone Gel, 21-23

Topical Transfer, 21-23

Trizivir, 5-6


 



V

Varenicline, 1-4


 



Z

Ziagen, 5-6

Zicam, 26-27

Zinc-Containing Intranasal Cold Remedies, 26-27

Zolendronic Acid, 13-15